X4 Pharmaceuticals (XFOR) Short Interest Ratio & Short Volume → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free XFOR Stock Alerts $0.98 -0.01 (-1.01%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability X4 Pharmaceuticals Short Interest DataCurrent Short Volume13,190,000 sharesPrevious Short Volume12,260,000 sharesChange Vs. Previous Month+7.59%Dollar Volume Sold Short$14.77 millionShort Interest Ratio / Days to Cover4.2Last Record DateApril 30, 2024Outstanding Shares167,940,000 sharesPercentage of Shares Shorted7.85%Today's Trading Volume1,162,483 sharesAverage Trading Volume2,667,488 sharesToday's Volume Vs. Average44% Short Selling X4 Pharmaceuticals ? Sign up to receive the latest short interest report for X4 Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatXFOR Short Interest Over TimeXFOR Days to Cover Over TimeXFOR Percentage of Float Shorted Over Time Ad Manward PressAmazon's betting big on this unknown AI companyAmazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company.Discover why this company X4 Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202413,190,000 shares $14.77 million +7.6%N/A4.2 $1.12 4/15/202412,260,000 shares $15.33 million -0.6%N/A5.1 $1.25 3/31/202412,330,000 shares $17.14 million -13.3%N/A5.8 $1.39 3/15/202414,220,000 shares $13.19 million -1.3%N/A7.4 $0.93 2/29/202414,400,000 shares $13.98 million +8.8%N/A8.1 $0.97 2/15/202413,230,000 shares $12.52 million +3.4%N/A6.6 $0.95 Get the Latest News and Ratings for XFOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for X4 Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202412,800,000 shares $10.00 million +6.8%N/A6.1 $0.78 1/15/202411,990,000 shares $9.83 million +3.2%N/A5.2 $0.82 12/31/202311,620,000 shares $9.74 million -1.0%N/A5.1 $0.84 12/15/202311,740,000 shares $8.38 million +2.8%N/A5.2 $0.71 11/30/202311,420,000 shares $8.91 million -0.3%N/A6.2 $0.78 11/15/202311,450,000 shares $9.00 million -0.5%N/A7.5 $0.79 10/31/202311,510,000 shares $9.21 million +5.8%N/A5.5 $0.80 10/15/202310,880,000 shares $9.70 million +2.5%N/A5.7 $0.89 9/30/202310,620,000 shares $11.58 million -2.4%N/A5.2 $1.09 9/15/202310,880,000 shares $12.08 million +5.7%N/A4.9 $1.11 8/31/202310,290,000 shares $13.17 million -6.8%N/A3.6 $1.28 8/15/202311,040,000 shares $13.25 million -8.4%N/A3.3 $1.20 7/31/202312,050,000 shares $21.57 million -11.2%N/A3.5 $1.79 7/15/202313,570,000 shares $25.51 million -5.7%N/A3.7 $1.88 6/30/202314,390,000 shares $27.92 million +57.4%N/A3.7 $1.94 6/15/20239,140,000 shares $20.75 million +7.0%N/A2.3 $2.27 5/31/20238,540,000 shares $17.34 million +189.5%N/A2.6 $2.03 5/15/20232,950,000 shares $4.48 million -2.6%N/A1.1 $1.52 4/30/20233,030,000 shares $4.45 million -14.2%N/A1.7 $1.47 4/15/20233,530,000 shares $4.06 million +86.8%N/A2.6 $1.15 3/31/20231,890,000 shares $1.64 million +10.5%N/A1.7 $0.87 3/15/20231,710,000 shares $1.55 million +34.7%N/A2.1 $0.91 2/28/20231,270,000 shares $1.19 million +22.1%N/A1.1 $0.94 2/15/20231,040,000 shares $1.04 million -3.7%N/A0.8 $1.00 1/31/20231,080,000 shares $1.11 million -13.6%N/A0.8 $1.03 1/15/20231,250,000 shares $1.51 million -20.9%N/A1 $1.21 12/30/20221,580,000 shares $1.57 million +17.9%N/A1.3 $0.99 12/15/20221,340,000 shares $1.08 million -12.4%N/A0.9 $0.81 11/30/20221,530,000 shares $2.30 million -0.7%N/A1.3 $1.50 11/15/20221,540,000 shares $2.93 million -4.9%N/A1.9 $1.90 10/31/20221,620,000 shares $3.08 million -1.8%N/A1.9 $1.90 10/15/20221,650,000 shares $3.33 million -8.8%N/A2.1 $2.02 9/30/20221,810,000 shares $3.10 million +272.0%N/A2.4 $1.71 9/15/2022486,600 shares $583,920.00 -11.3%N/A1.1 $1.20The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him XFOR Short Interest - Frequently Asked Questions What is X4 Pharmaceuticals' current short interest? Short interest is the volume of X4 Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 13,190,000 shares of XFOR short. Learn More on X4 Pharmaceuticals' current short interest. What is a good short interest ratio for X4 Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XFOR shares currently have a short interest ratio of 4.0. Learn More on X4 Pharmaceuticals's short interest ratio. Is X4 Pharmaceuticals' short interest increasing or decreasing? X4 Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 13,190,000 shares, an increase of 7.6% from the previous total of 12,260,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does X4 Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to X4 Pharmaceuticals: Cellectis S.A. (1.18%), Cardiff Oncology, Inc. (9.88%), Vaxart, Inc. (10.44%), Compugen Ltd. (2.25%), Cardiol Therapeutics Inc. (0.50%), Genfit S.A. (0.18%), Adverum Biotechnologies, Inc. (8.04%), Vigil Neuroscience, Inc. (4.61%), Elevation Oncology, Inc. (11.46%), Scilex Holding (8.38%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short X4 Pharmaceuticals stock? Short selling XFOR is an investing strategy that aims to generate trading profit from X4 Pharmaceuticals as its price is falling. XFOR shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against X4 Pharmaceuticals? A short squeeze for X4 Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XFOR, which in turn drives the price of the stock up even further. How often is X4 Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XFOR, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Cellectis Short Squeeze Cardiff Oncology Short Squeeze Vaxart Short Squeeze Compugen Short Squeeze Cardiol Therapeutics Short Squeeze Genfit Short Squeeze Adverum Biotechnologies Short Squeeze Vigil Neuroscience Short Squeeze Elevation Oncology Short Squeeze Scilex Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XFOR) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressAmazon's betting big on this unknown AI companyManward PressWall Street legend who predicted 2021 tech crash issues new warningChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News